[1]
“Metformin v/s glibenclamide : for intial therapy of type 2 diabetes mellitus in a tertiary care hospital, a comparative study, for efficacy and tolerability”, Int. J. of Res. in Pharmacology &Pharmacotherapeutics , vol. 8, no. 1, pp. 23–28, Mar. 2021, doi: 10.61096/ijrpp.v8.iss1.2019.23-28.